Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with <i>RYR1</i> gene mutation.

Salter, Brittany; Jessome, Matthew; Tarnopolsky, Mark; Yousuf, Haroon

Possible association between rhabdomyolysis and mRNA SARS-CoV-2 vaccination in a patient with RYR1 gene mutation.

Salter, Brittany; Jessome, Matthew; Tarnopolsky, Mark; Yousuf, Haroon.

Afiliação

Salter B; Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont. brittany.salter@medportal.ca.
Jessome M; Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
Tarnopolsky M; Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.
Yousuf H; Departments of Medicine (Salter, Yousuf), Rheumatology (Jessome) and Neurology (Tarnopolsky), McMaster University, Hamilton, Ont.

CMAJ ; 194(7): E252-E256, 2022 02 22.

Article em En | MEDLINE | ID: mdl-35193861

Assuntos

Vacina de mRNA-1273 contra 2019-nCoV/efeitos adversos; Rabdomiólise/diagnóstico; Vacina de mRNA-1273 contra 2019-nCoV/administração & dosagem; Adulto; Biomarcadores/sangue; COVID-19/epidemiologia; Causalidade; Creatina Quinase/sangue; Feminino; Humanos; Mutação; Rabdomiólise/sangue; Rabdomiólise/genética; Rabdomiólise/virologia; Canal de Liberação de Cálcio do Receptor de Rianodina; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD Base de dados: MEDLINE Assunto principal: Rabdomiólise / Vacina de mRNA-1273 contra 2019-nCoV Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: CMAJ Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google